Science and Technology
publicado em 15/03/2012 às 15h38:00
   Dê o seu voto:

Glaxo SmithKline and FAPESP launches call for health research

Cooperation Agreement allows contribution of $ 600,000, with a maximum approved for each project limited to $ 200,000

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Foto: GSK
Production line at GSK, the pharmaceutical industry maintains that research agreement with FAPESP
  « Previous
next »  
Production line at GSK, the pharmaceutical industry maintains that research agreement with FAPESP

The Foundation for Research Support of São Paulo and Brazil-Glaxo SmithKline (GSK) launched call for proposals for research under the cooperation agreement signed on February 28 institutions. The agreement will allow a contribution of funds up to $ 600,000, with a maximum approved for each project limited to $ 200,000, shared equally by GSK and FAPESP, to support research in the area of ​​Health developed in the State of Paul.

The priority areas for the development of collaborative research include topics such as respiratory diseases, metabolic, infectious, inflammatory and immunology, as well as tropical and neglected diseases and so-called rare diseases.

Other themes and subthemes relevant to public health in Brazil, including the application in the development of new drugs, may also be the object of the projects according to needs verified by a steering committee consisting of members of the cooperation of both institutions.

The purpose of the call is to promote research projects that lead to new knowledge, contributing to the construction of scientific and technological skills in health, with results that could potentially lead to applications with a market value in the areas covered.

May submit projects researchers from institutions of higher education and research, public and private, in the State of Sao Paulo. Conditions will apply the Support Program for Research in Partnership for Technological Innovation (PITE) of FAPESP. The research projects will be received until May 14.

The collaboration between GSK and FAPESP Brazil takes place within the Trust in Science Project, an international initiative that Glaxo SmithKline plans to invest $ 3 million in cooperative agreements with the subsequent FAPESP and also with the National Council for Scientific and Technological Development ( CNPq).

Source: FAPESP
   Palavras-chave:   FAPESP    Glaxo SmithKline    Brazil    Call    Search    GSK drugs   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Glaxo SmithKline and FAPESP launches call for health research
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Glaxo SmithKline and FAPESP launches call for health research


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
FAPESP    Glaxo SmithKline    Brazil    call    search    GSK drugs   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.